New Strategies for Craniofacial Repair and Replacement: A Brief Review

Journal of Craniofacial Surgery

Volumn 14, Issue 3, 2003, Pages 333-339

  Fong, Kenton D ^a   Nacamuli, Randall P ^a   Song, HanJoon M ^a   Warren, Stephen M ^a   Lorenz, H Peter ^a   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN;

ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CELL TRANSPLANTATION; CRANIOFACIAL MALFORMATION; GENE THERAPY; GENE VECTOR; HUMAN; METHODOLOGY; PLASTIC SURGERY; PROSTHESES AND ORTHOSES; REGENERATION; REVIEW; TISSUE ENGINEERING; TRANSPLANTATION;

ANIMALS; CELL TRANSPLANTATION; CELLS, CULTURED; CRANIOFACIAL ABNORMALITIES; GENE THERAPY; GENETIC VECTORS; HUMANS; MODELS, BIOLOGICAL; PROSTHESES AND IMPLANTS; RECOMBINANT PROTEINS; RECONSTRUCTIVE SURGICAL PROCEDURES; REGENERATION; TISSUE ENGINEERING;

EID: 0141837016     PISSN: 10492275     EISSN: 15363732     Source Type: Journal    
DOI: 10.1097/00001665-200305000-00011     Document Type: Article

References (72)

1. Mulliken JB, Glowacki J. Induced osteogenesis for repair and construction in the craniofacial region. Plast Reconstr Surg 1980; 65:553-560.
2. Bostrom R, Mikos A. Tissue engineering of bone. In: Atala A, Mooney DJ, Vacanti JP, Langer R, eds. Synthetic Biodegradable Polymer Scaffolds. Vol. 1. Boston: Birkhauser, 1997:215-234.
3. Mehrara BJ, Rowe NM, Steinbrech DS, et al. Rat mandibular distraction osteogenesis: II. Molecular analysis of transforming growth factor beta-1 and osteocalcin gene expression. Plast Reconstr Surg 1999; 103:536-547.
4. Warren SM, Mehrara BJ, Steinbrech DS, et al. Rat mandibular distraction osteogenesis: part III. Gradual distraction versus acute lengthening. Plast Reconstr Surg 2001; 107:441-453.
5. Warren SM, Greenwald JA, Spector JA, et al. New developments in cranial suture research. Plast Reconstr Surg 2001; 107:523-540.
6. Greenwald JA, Mehrara BJ, Spector JA, et al. Immature versus mature dura mater: II. Differential expression of genes important to calvarial reossification. Plast Reconstr Surg 2000; 106:630-638.
7. Greenwald JA, Mehrara BJ, Spector JA, et al. Biomolecular mechanisms of calvarial bone induction: immature versus mature dura mater. Plast Reconstr Surg 2000; 105:1382-1392.
8. Kawaguchi H, Nakamura K, Tabata Y, et al. Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2. J Clin Endocrinol Metab 2001; 86:875-880.
9. Sakai R, Miwa K, Eto Y. Local administration of activin promotes fracture healing in the rat fibula fracture model. Bone 1999; 25:191-196.
10. Kato T, Kawaguchi H, Hanada K, et al. Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits. J Orthop Res 1998; 16:654-659.
11. Higuchi T, Kinoshita A, Takahashi K, et al. Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling. J Periodontol 1999; 70:1026-1031.
12. Tielinen L, Manninen M, Puolakkainen P, et al. Combining transforming growth factor-beta1 to a bioabsorbable self-reinforced polylactide pin for osteotomy healing: an experimental study on rats. J Orthop Sci 1999; 4:421-430.
13. Tielinen L, Manninen M, Puolakkainen P, et al. Polylactide pin with transforming growth factor beta 1 in delayed osteotomy fixation. Clin Orthop 1998:312-322.
14. Raschke M, Kolbeck S, Bail H, et al. Homologous growth hormone accelerates healing of segmental bone defects. Bone 2001; 29:368-373.
15. Nakamura T, Hanada K, Tamura M, et al. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 1995; 136:1276-1284.
16. Hao Y, Dai K, Guo L, et al. Effects of recombinant human growth hormone r-hGH) on experimental osteoporotic fracture healing. Chin J Traumatol 2001; 4:102-105.
17. Valentin-Opran A, Wozney J, Csimma C, et al. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop 2002:110-120.
18. Marchac D, Renier D. Craniosynostosis. World J Surg 1989; 13:358-365.
19. Schilephake H. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 2002; 31:469-484.
20. Bosch C, Melsen B, Gibbons R, et al. Human recombinant transforming growth factor-beta 1 in healing of calvarial bone defects. J Craniofac Surg 1996; 7:300-310.
21. Ripamonti U, Crooks J, Petit JC, et al. Periodontal tissue regeneration by combined applications of recombinant human osteogenic protein-1 and bone morphogenetic protein-2. A pilot study in Chacma baboons (Papio ursinus). Eur J Oral Sci 2001; 109:241-248.
22. Hunt DR, Jovanovic SA, Wikesjo UM, et al. Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study. J Periodontol 2001; 72:651-658.
23. Stewart KJ, Weyand B, van't Hof RJ, et al. A quantitative analysis of the effect of insulin-like growth factor-1 infusion during mandibular distraction osteogenesis in rabbits. Br J Plast Surg 1999; 52:343-350.
24. Thaller SR, Dart A, Tesluk H. The effects of insulin like growth factor I on critical sized calvarial defects in Sprague Dawley rats. Ann Plas Surg 1993; 31:429-433.
25. Thaller SR, Hoyt J, Tesluk H, et al. The effect of insulin growth factor-1 on calvarial sutures in a Sprague-Dawley rat. J Craniofac Surg 1993; 4:35-39.
26. Thaller SR, Hoyt J, Tesluk H, et al. Effect of insulin-like growth factor-1 on zygomatic arch bone regeneration: a preliminary histological and histometric study. Ann Plast Surg 1993; 31:421-428.
27. Thaller SR, Lee TJ, Armstrong M, et al. Effect of insulin-like growth factor type 1 on critical-size defects in diabetic rats. J Craniofac Surg 1995; 6:218-223.
28. Thaller SR, Salzhauer MA, Rubinstein AJ, et al. Effect of insulin-like growth factor type I on critical size calvarial bone defects in irradiated rats. J Craniofac Surg 1998; 9:138-141.
29. Ripamonti U, Crooks J, Rueger DC. Induction of bone formation by recombinant human osteogenic protein-1 and sintered porous hydroxyapatite in adult primates. Plast Reconstr Surg 2001; 107:977-988.
30. Ashammakhi N, Peltoniemi H, Waris E, et al. Developments in craniomaxillofacial surgery: use of self-reinforced bioabsorbable osteofixation devices. Plast Reconstr Surg 2001; 108:167-180.
31. Tiainen J, Leinonen S, Ilomaki J, et al. Comparison of the pull-out forces of bioabsorbable polylactide/glycolide screws Biosorb and Lactosorb) and tacks: a study on the stability of fixation in human cadaver parietal bones. J Craniofac Surg 2002; 13:538-543.
32. Tiainen J, Veiranto M, Suokas E, et al. Bioabsorbable ciprofloxacin-containing and plain self-reinforced polylactide-polyglycolide 80/20 screws: pullout strength properties in human cadaver parietal bones. J Craniofac Surg 2002; 13:427-433.
33. Leinonen S, Suokas E, Veiranto M, et al. Holding power of bioabsorbable ciprofloxacin-containing self-reinforced poly-L/DL-lactide 70/30 bioactive glass 13 miniscrews in human cadaver bone. J Craniofac Surg 2002; 13:212-8.
34. Tepper OM, Mehrara BJ. Gene therapy in plastic surgery. Plast Reconstr Surg 2002; 109:716-734.
35. Mack CA, Magovern CJ, Budenbender KT, et al. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J Vasc Surg 1998; 27:699-709.
36. Lindsey WH. Osseous tissue engineering with gene therapy for facial bone reconstruction. Laryngoscope 2001; 111:1128-1136.
37. Sirola K. Regeneration of defects in the calvaria. Ann Med Exp Biol Fenn 1960; 38:1-87.
38. Hobar PC, Schreiber JS, McCarthy JG, et al. The role of the dura in cranial bone regeneration in the immature animal. Plast Reconstr Surg 1993; 92:405-410.
39. Hobar PC, Masson JA, Wilson R, et al. The importance of the dura in craniofacial surgery. Plast Reconstr Surg 1996; 98:217-225.
40. Reid CA, McCarthy JG, Kolber AB. A study of regeneration in parietal bone defects in rabbits. Plast Reconstr Surg 1981; 67:591-596.
41. Shillitoe EJ, Noonan S, Hinkle CC, et al. Transduction of normal and malignant oral epithelium by particle bombardment. Cancer Gene Ther 1998; 5:176-182.
42. Bonadio J. Tissue engineering via local gene delivery. J Mol Med 2000; 78:303-311.
43. Salyapongse AN, Billiar TR, Edington H. Gene therapy and tissue engineering. Clin Plast Surg 1999; 26:663-676.
44. Campbell RB, Balasubramanian SV, Straubinger RM. Phospholipid-cationic lipid interactions: influences on membrane and vesicle properties. Biochim Biophys Acta 2001; 1512:27-39.
45. Banerjee R. Liposomes: applications in medicine. J Biomater Appl 2001; 16:3-21.
46. Fielding RM. Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective. Clin Pharmacokinet 1991; 21:155-164.
47. Nabel GJ, Nabel EG, Yang ZY, et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A 1993; 90:11307-11309.
48. Hottiger MO, Dam TN, Nickoloff BJ, et al. Liposome-mediated gene transfer into human basal cell carcinoma. Gene Ther 1999; 6:1929-1935.
49. Colin M, Harbottle RP, Knight A, et al. Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells. Gene Ther 1998; 5:1488-1498.
50. Hood JD, Bednarski M, Frausto R, et al. Tumor regression by targeted gene delivery to the neovasculature. Science 2002; 296:2404-2407.
51. Bonadio J, Smiley E, Patil P, et al. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 1999; 5:753-759.
52. Giannobile WV. Periodontal tissue engineering by growth factors. Bone 1996; 19:23S-37S.
53. Goldstein SA. In vivo nonviral delivery factors to enhance bone repair. Clin Orthop 2000; 379S:113-119.
54. Shea LD, Smiley E, Bonadio J, et al. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 1999; 17:551-554.
55. Hingorani MM, O'Donnell M. A tale of toroids in DNA metabolism. Nat Rev Mol Cell Biol 2000; 1:22-30.
56. Luo D, Saltzman WM. Synthetic DNA delivery systems. Nat Biotechnol 2000; 18:33-37.
57. Luo D, Saltzman WM. Enhancement of transfection by physical concentration of DNA at the cell surface. Nat Biotechnol 2000; 18:893-895.
58. Warren SM, Sylvester K, Chen CM, et al. New directions in bioabsorbable technology. Orthopedics 2002; 25:s1201-1210.
59. Golan R, Pietrasanta LI, Hsieh W, et al. DNA toroids: stages in condensation. Biochemistry 1999; 38:14069-14076.
60. Segura T, Shea LD. Surface-tethered DNA complexes for enhanced gene delivery. Bioconjug Chem 2002; 13:621-629.
61. Smith AG. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 2001; 17:435-462.
62. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276:71-74.
63. Shen FH, Visger JM, Balian G, et al. Systemically administered mesenchymal stromal cells transduced with insulin-like growth factor-I localize to a fracture site and potentiate healing. J Orthop Trauma 2002; 16:651-659.
64. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-147.
65. Ohgushi H, Caplan AI. Stem cell technology and bioceramics: from cell to gene engineering. J Biomed Mater Res 1999; 48:913-927.
66. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7:211-228.
67. Mizuno H, Zuk PA, Zhu M, et al. Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg 2002; 109:199-209.
68. Orringer JS, Shaw WW, Borud LJ, et al. Total mandibular and lower lip reconstruction with a prefabricated osteocutaneous free flap. Plast Reconstr Surg 1999; 104:793-797.
69. Ogle BM, Platt JL. Genetic therapies and xenotransplantation. Expert Opin Biol Ther 2002; 2:299-310.
70. Sandrin MS, Loveland BE, McKenzie IF. Genetic engineering for xenotransplantation. J Card Surg 2001; 16:448-457.
71. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299:411-414.
72. Petit-Zeman S. Regenerative medicine. Nat Biotechnol 2001; 19:201-206.